[go: up one dir, main page]

NO20031656D0 - Kombinasjon omfattende camptothecin og et stillbenderivat for behandling avcancer - Google Patents

Kombinasjon omfattende camptothecin og et stillbenderivat for behandling avcancer

Info

Publication number
NO20031656D0
NO20031656D0 NO20031656A NO20031656A NO20031656D0 NO 20031656 D0 NO20031656 D0 NO 20031656D0 NO 20031656 A NO20031656 A NO 20031656A NO 20031656 A NO20031656 A NO 20031656A NO 20031656 D0 NO20031656 D0 NO 20031656D0
Authority
NO
Norway
Prior art keywords
camptothecin
cancer
treatment
combination
bone derivative
Prior art date
Application number
NO20031656A
Other languages
English (en)
Other versions
NO20031656L (no
NO324844B1 (no
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20031656D0 publication Critical patent/NO20031656D0/no
Publication of NO20031656L publication Critical patent/NO20031656L/no
Publication of NO324844B1 publication Critical patent/NO324844B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20031656A 2000-10-27 2003-04-10 Farmasoytisk preparat omfattende CPT-11 og combretastatin og anvendelse for behandling av cancer. NO324844B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24343100P 2000-10-27 2000-10-27
US24558200P 2000-11-06 2000-11-06
US25013800P 2000-12-01 2000-12-01
PCT/EP2001/012985 WO2002034244A2 (en) 2000-10-27 2001-10-25 A combination comprising camptothecin and a stilbene derivative for the treatment of cancer

Publications (3)

Publication Number Publication Date
NO20031656D0 true NO20031656D0 (no) 2003-04-10
NO20031656L NO20031656L (no) 2003-04-10
NO324844B1 NO324844B1 (no) 2007-12-17

Family

ID=27399663

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031656A NO324844B1 (no) 2000-10-27 2003-04-10 Farmasoytisk preparat omfattende CPT-11 og combretastatin og anvendelse for behandling av cancer.

Country Status (21)

Country Link
US (1) US6562834B2 (no)
EP (1) EP1333820A2 (no)
JP (1) JP2004517821A (no)
KR (1) KR100742524B1 (no)
CN (1) CN1200712C (no)
AU (2) AU1602902A (no)
BG (1) BG107806A (no)
BR (1) BR0114856A (no)
CA (1) CA2426898A1 (no)
EA (1) EA005400B1 (no)
EE (1) EE200300184A (no)
HR (1) HRP20030382A2 (no)
HU (1) HUP0302629A3 (no)
IL (1) IL155509A0 (no)
MX (1) MXPA03002882A (no)
NO (1) NO324844B1 (no)
NZ (1) NZ524855A (no)
PL (1) PL365685A1 (no)
SK (1) SK5122003A3 (no)
WO (1) WO2002034244A2 (no)
YU (1) YU29803A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183266A1 (en) * 2001-03-15 2002-12-05 Aventis Pharma, S.A. Combination comprising combretastatin and anticancer agents
US20080075762A1 (en) * 2001-10-03 2008-03-27 Paul Tardi Compositions for delivery of drug combinations
US7850990B2 (en) * 2001-10-03 2010-12-14 Celator Pharmaceuticals, Inc. Compositions for delivery of drug combinations
CA2383259A1 (en) * 2002-04-23 2003-10-23 Celator Technologies Inc. Synergistic compositions
CN101085743B (zh) * 2006-06-06 2012-02-15 浙江大德药业集团有限公司 含氟烷氧基康普立停衍生物及制法和用途
TW200819409A (en) * 2006-10-19 2008-05-01 Univ Taipei Medical Z-stilbenes derivatives and the pharmaceutical composition thereof
JP2014512337A (ja) 2011-01-28 2014-05-22 ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション スチルベン類似体およびがんを処置する方法
JP2014527036A (ja) 2011-06-27 2014-10-09 ザ ジャクソン ラボラトリー 癌および自己免疫疾患の処置のための方法および組成物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116015A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Antitumor agent
JPS57116074A (en) 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4399276A (en) 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
US4473692A (en) 1981-09-04 1984-09-25 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
JPS58154582A (ja) 1982-03-10 1983-09-14 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体およびその製造法
JPS595188A (ja) 1982-06-30 1984-01-12 Yakult Honsha Co Ltd １０−ヒドロキシカンプトテシンの製造法
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
US4981968A (en) 1987-03-31 1991-01-01 Research Triangle Institute Synthesis of camptothecin and analogs thereof
CA1332413C (en) 1987-06-25 1994-10-11 Kabushiki Kaisha Yakult Honsha Camptothecin derivatives and process for preparing same
US5004758A (en) 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JPH0615547B2 (ja) 1988-01-20 1994-03-02 株式会社ヤクルト本社 新規なカンプトテシン誘導体
JP2524804B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体及びその製造法
JP2524803B2 (ja) 1988-03-29 1996-08-14 株式会社ヤクルト本社 新規なカンプトテシン誘導体およびその製造法
EP0540099B1 (en) 1991-10-29 1996-04-17 Glaxo Wellcome Inc. Water soluble camptothecin derivatives
TW325458B (en) 1993-09-08 1998-01-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions comprising the same for anti-cancer
TW334418B (en) 1995-03-07 1998-06-21 Ajinomoto Kk Stilbene derivatives and pharmaceutical compositions
US6504029B1 (en) 1995-04-10 2003-01-07 Daiichi Pharmaceutical Co., Ltd. Condensed-hexacyclic compounds and a process therefor
GB9510716D0 (en) 1995-05-26 1995-07-19 Pharmacia Spa Substituted camptothecin derivatives and process for their preparation
US5663177A (en) 1995-05-31 1997-09-02 Smithkline Beecham Corporation Water soluble camptothecin analogs
US5670500A (en) 1995-05-31 1997-09-23 Smithkline Beecham Corporation Water soluble camptothecin analogs
ATE224900T1 (de) 1995-06-21 2002-10-15 Sod Conseils Rech Applic Camptothecinanaloge, verfahren zur ihrer herstellung, ihre verwendungals arzneimittel und diese enthaltende pharmazeutische zusammenfassungen
JP3054669B2 (ja) 1995-10-16 2000-06-19 余川商事株式会社 積雪落下防止装置
JPH11296051A (ja) 1998-04-08 1999-10-29 Canon Inc プロセスカートリッジ
PT1144011E (pt) * 1998-12-11 2010-06-16 Coulter Pharm Inc Compostos pró-fármacos e processo para a sua preparação
GB9903404D0 (en) * 1999-02-16 1999-04-07 Angiogene Pharm Ltd Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis
CA2432792C (en) 2000-12-22 2012-04-03 Bristol-Myers Squibb Company Methods for modulating tumor growth and metastasis

Also Published As

Publication number Publication date
KR20030082544A (ko) 2003-10-22
MXPA03002882A (es) 2004-12-03
WO2002034244A3 (en) 2003-05-30
SK5122003A3 (en) 2003-12-02
EP1333820A2 (en) 2003-08-13
EE200300184A (et) 2003-08-15
IL155509A0 (en) 2003-11-23
HUP0302629A3 (en) 2005-05-30
WO2002034244A2 (en) 2002-05-02
YU29803A (sh) 2006-05-25
BG107806A (bg) 2004-06-30
CA2426898A1 (en) 2002-05-02
BR0114856A (pt) 2004-06-15
CN1200712C (zh) 2005-05-11
NO20031656L (no) 2003-04-10
EA005400B1 (ru) 2005-02-24
KR100742524B1 (ko) 2007-08-02
NO324844B1 (no) 2007-12-17
NZ524855A (en) 2004-10-29
AU1602902A (en) 2002-05-06
HRP20030382A2 (en) 2005-04-30
EA200300516A1 (ru) 2003-08-28
AU2002216029B2 (en) 2006-01-05
JP2004517821A (ja) 2004-06-17
CN1471396A (zh) 2004-01-28
US20020115677A1 (en) 2002-08-22
PL365685A1 (en) 2005-01-10
HUP0302629A2 (hu) 2003-11-28
HK1058623A1 (en) 2004-05-28
US6562834B2 (en) 2003-05-13

Similar Documents

Publication Publication Date Title
NO20014560D0 (no) Quinasoliner og terapautisk anvendelse derav
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
NO20011964L (no) Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav
NO20024610L (no) Synergistiske metoder og blandinger for behandling av kreft
DK1267650T3 (da) Tobakbehandling
AU6147401A (en) Compositions and methods for the treatment of cancer
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
DE50111900D1 (de) Medizinisches implantat
EE200200571A (et) Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
EP1383573A4 (en) METHOD AND DEVICE FOR THE TREATMENT OF ANGRYED TISSUE
HUP0300848A3 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
NO20014706L (no) Innretning og fremgangsmåter for hjertekirurgi
ATE297914T1 (de) Hydroxyphenyl-piperazinyl-methyl-benzamid- derivate zur schmerzbehandlung
EE200200577A (et) Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks
NO20031656L (no) Kombinasjon omfattende camptothecin og et stillbenderivat for behandling avcancer
GB0001710D0 (en) Therapeutic treatment
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
IS6707A (is) Efnablanda til forvarna og meðhöndlunar á krabbameini
AU2096002A (en) Therapeutic treatment
NO20020291D0 (no) Preventive og terapeutiske midler for kreft
NO20022482D0 (no) 2-arylkinolinderivater, fremgangsmåte og terapeutisk anvendelse derav
NO20010630L (no) Krummet trapp og trappetrinn for krummet trapp
AU6884801A (en) Therapeutic compounds and methods
ATE285468T1 (de) Gewebehandlungszubereitung
GB0008161D0 (en) Treatment of cancer